Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The monkey's hair loss was due to an autoimmune disease, not genetics.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.